Horrell Capital Management, Inc. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 118 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Horrell Capital Management, Inc. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2017$1,0000.0%500.0%0.00%0.0%
Q3 2017$1,0000.0%50
-90.0%
0.00%0.0%
Q2 2017$1,000
-50.0%
5000.0%0.00%0.0%
Q1 2017$2,0000.0%5000.0%0.00%0.0%
Q4 2016$2,000
-33.3%
5000.0%0.00%
-50.0%
Q3 2016$3,0000.0%5000.0%0.00%0.0%
Q2 2016$3,0005000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders